Botulinum neurotoxin type A precursor
Botulinum neurotoxin type A precursor Brand names, Botulinum neurotoxin type A precursor Analogs
Botulinum neurotoxin type A precursor Brand Names Mixture
- No information avaliable
Botulinum neurotoxin type A precursor Chemical_Formula
C6760H10447N1743O2010S32
Botulinum neurotoxin type A precursor RX_link
http://www.rxlist.com/cgi/generic2/botulinumtoxin.htm
Botulinum neurotoxin type A precursor fda sheet
Botulinum neurotoxin type A precursor msds (material safety sheet)
Botulinum neurotoxin type A precursor Synthesis Reference
No information avaliable
Botulinum neurotoxin type A precursor Molecular Weight
149322.7
Botulinum neurotoxin type A precursor Melting Point
No information avaliable
Botulinum neurotoxin type A precursor H2O Solubility
No information avaliable
Botulinum neurotoxin type A precursor State
Liquid
Botulinum neurotoxin type A precursor LogP
-0.368
Botulinum neurotoxin type A precursor Dosage Forms
Solution
Botulinum neurotoxin type A precursor Indication
For treatment of cervical dystonia, axillary hyperhidrosis, strabismus, facial wrinkles
Botulinum neurotoxin type A precursor Pharmacology
Myobloc inhibits acetylcholine release at the neuromuscular junction via a three stage process: 1) Heavy Chain mediated neurospecific binding of the toxin, 2) internalization of the toxin by receptor-mediated endocytosis, and 3) ATP and pH dependent translocation of the Light Chain to the neuronal cytosol where it acts as a zinc-dependent endoprotease cleaving polypeptides essential for neurotransmitter release.
Botulinum neurotoxin type A precursor Absorption
No information avaliable
Botulinum neurotoxin type A precursor side effects and Toxicity
No information avaliable
Botulinum neurotoxin type A precursor Patient Information
No information avaliable
Botulinum neurotoxin type A precursor Organisms Affected
Humans and other mammals
